Combined meningitis vaccine

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 39/095 (2006.01) A61K 39/116 (2006.01) A61P 31/04 (2006.01) A61P 37/04 (2006.01)

Patent

CA 2689871

A combined vaccine comprising a Haemophilus influenzae type B (Hib) oligosaccharide conjugate and a Neisseria meningitidis serogroup C (MenC) oligosaccharide conjugate. The combination vaccine is free from interference between the antigens used. The vaccine may also include a Neisseria meningitidis serogroup B(MenB) oligosaccharide conjugate. The vaccine may be used in the prophylaxis or treatment of bacterial meningitis and allows economical, safe and expedient vaccination against the prevalent causes of meningitis. Advantageously, carrier priming may be exploited in order to maximize response to the vaccine, for example using a diphtheria, pertussis and tetanus (DTP) vaccine. The oligosaccharides are preferably size-selected and advantageously have a degree of polymerization of 4 or more.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combined meningitis vaccine does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combined meningitis vaccine, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combined meningitis vaccine will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1746274

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.